Consistent with this interpretation, we reported dysregulated secretion and/or ECM assembly of fibronectin, fibrillin-1, and COL1 in WMS patient–derived skin fibroblasts harboring an ADAMTS17 mutation (Karoulias et al, 2020a). This evidence concerns the gene FBN1 and Weill-Marchesani syndrome.